• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名复发性心包炎职业运动员的复杂管理决策

Complex Management Decisions in a Professional Athlete With Recurrent Pericarditis.

作者信息

Klein Benjamin M, Dugan Eunice S, LaCombe Andrew D, Ruthmann Nicholas P, Roselli Eric E, Klein Allan L, Emery Michael S

机构信息

Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

JACC Case Rep. 2022 Sep 7;4(17):1090-1093. doi: 10.1016/j.jaccas.2022.05.015.

DOI:10.1016/j.jaccas.2022.05.015
PMID:36124145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9481902/
Abstract

A 32-year-old professional athlete developed chronic recurrent pericarditis despite standard medical therapy. Etiology included postpericardiotomy syndrome, viral, or COVID-19 vaccine related, all potentially exacerbated by intense exercise. Treatment and return-to-play decisions were complicated by potential side-effect profile of therapies and ability to limit exercise as a professional athlete. ().

摘要

一名32岁的职业运动员尽管接受了标准药物治疗,仍患上了慢性复发性心包炎。病因包括心包切开术后综合征、病毒感染或与新冠病毒疫苗相关,所有这些病因都可能因高强度运动而加重。由于治疗的潜在副作用以及作为职业运动员限制运动的能力,治疗和恢复比赛的决策变得复杂。()

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d4/9481902/86ab35aa24eb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d4/9481902/15f409e4c7a9/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d4/9481902/86ab35aa24eb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d4/9481902/15f409e4c7a9/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d4/9481902/86ab35aa24eb/gr1.jpg

相似文献

1
Complex Management Decisions in a Professional Athlete With Recurrent Pericarditis.一名复发性心包炎职业运动员的复杂管理决策
JACC Case Rep. 2022 Sep 7;4(17):1090-1093. doi: 10.1016/j.jaccas.2022.05.015.
2
Refractory Recurrent Pericarditis After Pericardiectomy in a Young Woman.一名年轻女性心包切除术后难治性复发性心包炎
JACC Case Rep. 2021 Dec 1;3(17):1877-1882. doi: 10.1016/j.jaccas.2021.10.006.
3
Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis.心脏磁共振引导下的管理在复发性心包炎患者中的应用价值
Am J Cardiol. 2015 Feb 15;115(4):542-7. doi: 10.1016/j.amjcard.2014.11.041. Epub 2014 Dec 1.
4
Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis.在急性和复发性心包炎中使用阿司匹林、非甾体抗炎药、皮质类固醇和秋水仙碱治疗。
Heart Fail Rev. 2013 May;18(3):355-60. doi: 10.1007/s10741-012-9328-9.
5
Inflamed Colon and Pericardium: A Rare Combination of Colitis and Recurrent Pericarditis.发炎的结肠和心包:结肠炎与复发性心包炎的罕见组合。
JACC Case Rep. 2021 May 26;3(9):1227-1230. doi: 10.1016/j.jaccas.2021.04.009. eCollection 2021 Aug 4.
6
Recurrent pericarditis in children and adolescents: a multicentre cohort study.儿童和青少年复发性心包炎:一项多中心队列研究。
J Cardiovasc Med (Hagerstown). 2016 Sep;17(9):707-12. doi: 10.2459/JCM.0000000000000300.
7
Intravenous immunoglobulin therapy for refractory recurrent pericarditis.静脉注射免疫球蛋白治疗难治性复发性心包炎。
Pediatrics. 2014 Nov;134(5):e1441-6. doi: 10.1542/peds.2013-3900. Epub 2014 Oct 6.
8
Postpericardiotomy syndrome: its diagnosis and treatment after muscle flap closure of an infected sternal wound.心包切开术后综合征:感染性胸骨伤口肌瓣闭合后的诊断与治疗
Plast Reconstr Surg. 1995 Sep;96(3):725-7.
9
The Role of Colchicine in Pericardial Syndromes.秋水仙碱在心包综合征中的作用。
Curr Pharm Des. 2018;24(6):702-709. doi: 10.2174/1381612824666180116101823.
10
Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome.秋水仙碱治疗心包炎及心包切开术后综合征价值的荟萃分析。
BMC Cardiovasc Disord. 2019 Sep 2;19(1):207. doi: 10.1186/s12872-019-1190-4.

引用本文的文献

1
The Role of the Advanced Practice Provider in a Pericardial Center of Excellence.高级执业提供者在卓越心包疾病中心的作用。
Curr Cardiol Rep. 2025 Mar 10;27(1):69. doi: 10.1007/s11886-025-02205-y.

本文引用的文献

1
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection.与 COVID-19 疫苗接种或 SARS-CoV-2 感染相关的心肌炎、心包炎和心律失常风险。
Nat Med. 2022 Feb;28(2):410-422. doi: 10.1038/s41591-021-01630-0. Epub 2021 Dec 14.
2
The Impact of Physical Activity on Pericarditis.体力活动对心包炎的影响。
Curr Cardiol Rep. 2021 Aug 27;23(10):150. doi: 10.1007/s11886-021-01578-0.
3
Myocarditis With COVID-19 mRNA Vaccines.COVID-19 mRNA 疫苗相关心肌炎。
Circulation. 2021 Aug 10;144(6):471-484. doi: 10.1161/CIRCULATIONAHA.121.056135. Epub 2021 Jul 20.
4
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.白细胞介素-1受体拮抗剂rilonacept治疗复发性心包炎的3期试验
N Engl J Med. 2021 Jan 7;384(1):31-41. doi: 10.1056/NEJMoa2027892. Epub 2020 Nov 16.
5
Imaging-Guided Therapies for Pericardial Diseases.影像学引导下的心包疾病治疗。
JACC Cardiovasc Imaging. 2020 Jun;13(6):1422-1437. doi: 10.1016/j.jcmg.2019.08.027. Epub 2019 Nov 13.
6
Occurrence of Postpericardiotomy Syndrome: Association With Operation Type and Postoperative Mortality After Open-Heart Operations.心包切开后综合征的发生:与心脏直视手术后手术类型和术后死亡率的关系。
J Am Heart Assoc. 2018 Nov 20;7(22):e010269. doi: 10.1161/JAHA.118.010269.
7
Post-pericardiotomy Syndrome.心包切开术后综合征
Curr Cardiol Rep. 2016 Nov;18(11):116. doi: 10.1007/s11886-016-0791-0.
8
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology.心血管异常竞技运动员的资格与取消资格建议:前言、原则及一般考量:美国心脏协会和美国心脏病学会的科学声明
J Am Coll Cardiol. 2015 Dec 1;66(21):2343-2349. doi: 10.1016/j.jacc.2015.09.032. Epub 2015 Nov 2.
9
Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial.秋水仙碱预防心包切开术后综合征和术后心房颤动:COPPS-2 随机临床试验。
JAMA. 2014 Sep 10;312(10):1016-23. doi: 10.1001/jama.2014.11026.
10
Contemporary features, risk factors, and prognosis of the post-pericardiotomy syndrome.心包切开术后综合征的现代特征、危险因素和预后。
Am J Cardiol. 2011 Oct 15;108(8):1183-7. doi: 10.1016/j.amjcard.2011.06.025. Epub 2011 Jul 26.